|
|
|
|
|
by nonbel
3366 days ago
|
|
I quickly looked through your links. The first article you link seems to lack any control group (which we need to assess the proportion of pre-existing mutant cells), the second is primary research but does not mention CRISPR-Cas9, and the other two are review articles that don't contain any quantitative data. As mentioned, I only looked quickly, but I do not think any will be helpful on the point I am bringing up. Let me know if I missed it. |
|